Neuralink human trials approved
Neuralink announces that it has received FDA approval for human trials. Musk congratulates the team in a tweet.
We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study! This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our technology to help many people. Recruitment is not yet open for our clinical trial. We’ll announce more information on this soon!
Congratulations Neuralink team! https://t.co/AWZGf33UDr
— Elon Musk (@elonmusk) May 26, 2023
Musk: Neuralink human trials to begin in six months
At an event at Neuralink HQ, Musk says he expects the wireless brain chip developed by Neuralink to begin human clinical trials in six months, after the company missed earlier timelines he had set. Musk says the first two human applications of the dvice will be in restoring vision and enabling movement of muscles in people who cannot do so
Even if someone has never had vision, ever, like they were born blind, we believe we can still restore vision
Musk says human trials will progress slowly, and that he plans to get one of the chips himself.
We want to be extremely careful and certain that it will work well before putting a device into a human. The progress at first, particularly as it applies to humans, will seem perhaps agonizingly slow, but we are doing all of the things to bring it to scale in parallel. So, in theory, progress should be exponential.
